Ifp Advisors, Inc Ultragenyx Pharmaceutical Inc. Transaction History

Ifp Advisors, Inc

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 18, 2023	SELL	$36.99 - $48.71 $5,733 - $7,550	-155 Reduced 67.98%	73 $2,000
Q4 2022 Feb 07, 2023	BUY	$33.72 - $46.33 $2,899 - $3,984	86 Added 60.56%	228 $16,000
Q2 2022 Sep 06, 2022	BUY	$45.8 - $85.4 $6,503 - $12,126	142 New	142 $10,000
Q2 2022 Aug 12, 2022	SELL	$45.8 - $85.4 $6,503 - $12,126	-142 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$62.2 - $84.4 $8,832 - $11,984	142 New	142 $10,000
Q3 2021 Oct 06, 2021	SELL	$77.92 - $102.4 $311 - $409	-4 Closed	0 $0
Q2 2021 Jul 13, 2021	SELL	$92.19 - $115.71 $921 - $1,157	-10 Reduced 71.43%	4 $0
Q1 2021 Apr 30, 2021	SELL	$106.9 - $167.73 $1,924 - $3,019	-18 Reduced 56.25%	14 $2,000
Q4 2020 Jan 25, 2021	BUY	$84.4 - $177.39 $1,856 - $3,902	22 Added 220.0%	32 $4,000
Q3 2020 Oct 29, 2020	BUY	$72.98 - $90.0 $729 - $900	10 New	10 $1,000
Q2 2020 Aug 05, 2020	BUY	$46.91 - $78.22 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$33.8 - $62.9 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$36.08 - $45.83 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$42.5 - $63.11 $0 - $0	0 New	0 $0
Q4 2018 Jan 23, 2019	SELL	$38.89 - $77.3 $544 - $1,082	-14 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$48.54 - $85.31 $679 - $1,194	14 New	14 $0
Q4 2017 Jan 24, 2018	SELL	$43.54 - $57.32 $174 - $229	-4 Closed	0 $0
Q2 2016 Jun 03, 2019	BUY	N/A	4	4 $0

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.